Showing results (1591-1600 of 2,008) with videos related to

Sort By:
Pageof 201
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2016
Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic SclerosisZoe E Betteridge, Felix Woodhead, Hui Lu, et al.
Clinical and Experimental Medicine|August 10, 2021
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung diseaseErin M Wilfong, Katherine N Vowell, Kaitlyn E Bunn, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 23, 2023
Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjectsSteinn Jonsson, Wilbur A Franklin, Marileila Varella-Garcia, et al.
Aging Brain|July 6, 2023
Alteration of brain function and systemic inflammatory tone in older adults by decreasing the dietary palmitic acid intakeJulie A Dumas, Janice Y Bunn, Michael A LaMantia, et al.
World Journal of Clinical Oncology|January 13, 2021
Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patientsZachary C Taylor, Erin A Kaya, Jeffrey D Bunn, et al.
World Journal of Oncology|October 29, 2020
Clinicopathologic Features and Survival Trends for Acinic Cell Carcinoma of the Major Salivary Glands: A Surveillance, Epidemiology, and End Results Population AnalysisErin A Kaya, Zachary C Taylor, Brian J Mitchell, et al.
Experimental and Clinical Psychopharmacology|December 19, 2017
Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine contentChristopher A Arger, Sarah H Heil, Stacey C Sigmon, et al.
Molecular Oncology|June 8, 2020
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distributionDavid Dora, Christopher Rivard, Hui Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancerD C Ihde, A B Deisseroth, A S Lichter, et al.
Cancer|December 15, 1982
The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypesP A Radice, M J Matthews, D C Ihde, et al.
Pageof 201